Details of the Drug Formulaction

General Information of Drug Formulation (ID: F15481)

• Formulation Name: Nizatidine 150 mg capsule
• Company: Mylan Pharamceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Nizatidine	(DMGFV3Z)	Acid-reflux disorder	DA22	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Allura red AC dye	(E00338)	33258	Colorant
Ammonia	(E00007)	222	Alkalizing agent
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Butyl alcohol	(E00011)	263	Flavoring agent; Solvent
D&C red no. 28	(E00491)	6097185	Colorant
FD&C blue no. 1	(E00263)	19700	Colorant
FD&C red no. 3	(E00629)	Not Available	Colorant
Isopropyl alcohol	(E00070)	3776	Antimicrobial preservative; Solvent
Magnesium stearate	(E00208)	11177	lubricant
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent